Track record shows rational portfolio management and disciplined reinvestment. 2024 divestitures of De‑Sta‑Co and ESG simplified the portfolio and monetized non‑core assets. 2025 bolt‑ons in measurement (SIKORA), cryogenics (Cryo‑Mach) and hygienic pumps (ipp) bolster secular growth vectors like electrification, HPC thermal management and bioprocessing.
Capital returns balanced: 2025 dividends paid were 283 million dollars with the dividend raised for the 70th consecutive year, and a 500 million dollar ASR launched in November 2025 with additional open‑market repurchases. Management targets double‑digit returns on acquired capital within 3 to 4 years.







